Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,961 | 6 | 68.2% |
| Food and Beverage | $916.26 | 13 | 31.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $1,380 | 8 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,278 | 9 | $0 (2019) |
| Nevro Corp. | $136.70 | 1 | $0 (2017) |
| United Therapeutics Corporation | $82.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $82.87 | 1 | United Therapeutics Corporation ($82.87) |
| 2019 | $1,278 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,278) |
| 2018 | $44.00 | 1 | Vertex Pharmaceuticals Incorporated ($44.00) |
| 2017 | $1,472 | 8 | VERTEX PHARMACEUTICALS INCORPORATED ($1,336) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2023 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $82.87 | General |
| 11/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $115.00 | General |
| 11/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $515.34 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $321.68 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $111.23 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $49.87 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $49.87 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.79 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.79 | General |
| 10/18/2018 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $44.00 | General |
| 11/02/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $107.14 | General |
| 10/19/2017 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $136.70 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/02/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $567.84 | General |
| 05/02/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $352.12 | General |
| 05/02/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $88.64 | General |
| 05/02/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 05/02/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 05/01/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $125.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 67 | 93 | $16,197 | $4,593 |
| 2022 | 9 | 180 | 231 | $48,121 | $13,415 |
| 2021 | 6 | 114 | 118 | $7,364 | $2,329 |
| 2020 | 7 | 120 | 136 | $29,689 | $7,803 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 28 | 33 | $9,213 | $2,281 | 24.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 35 | $6,459 | $2,208 | 34.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 25 | 25 | $525.00 | $103.84 | 19.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 52 | $13,104 | $4,335 | 33.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 13 | 15 | $10,416 | $2,371 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 34 | $8,845 | $2,222 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 16 | $6,082 | $1,675 | 27.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 22 | $3,872 | $1,272 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $3,924 | $1,105 | 28.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 45 | 45 | $945.00 | $233.71 | 24.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 21 | 21 | $483.00 | $107.03 | 22.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 15 | 15 | $450.00 | $94.83 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 19 | $4,535 | $1,439 | 31.7% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 13 | 13 | $732.00 | $239.72 | 32.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 35 | 36 | $756.00 | $234.21 | 31.0% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 17 | 17 | $510.00 | $168.98 | 33.1% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 21 | 21 | $483.00 | $154.35 | 32.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 12 | 12 | $348.00 | $93.50 | 26.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 13 | 18 | $11,994 | $3,374 | 28.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 18 | 20 | $5,672 | $1,181 | 20.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 16 | 19 | $3,852 | $1,108 | 28.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 18 | $3,140 | $1,005 | 32.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $3,970 | $850.16 | 21.4% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2020 | 31 | 33 | $693.00 | $186.71 | 26.9% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 16 | 16 | $368.00 | $98.50 | 26.8% |
About Dr. Aaron Trimble, M.D
Dr. Aaron Trimble, M.D is a Pulmonary Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1932498862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Trimble, M.D has received a total of $2,877 in payments from pharmaceutical and medical device companies, with $82.87 received in 2023. These payments were reported across 19 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($1,961).
As a Medicare-enrolled provider, Trimble has provided services to 481 Medicare beneficiaries, totaling 578 services with total Medicare billing of $28,140. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Portland, OR
- Active Since 03/31/2011
- Last Updated 08/03/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1932498862
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $136.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Portland
Jordan Fein, M.d, M.D
Pulmonary Disease — Payments: $69,409
Granthem Farr, Do, DO
Pulmonary Disease — Payments: $66,353
Melvin Morganroth, Md, MD
Pulmonary Disease — Payments: $23,131
Dr. Bishoy Zakhary, Md, MD
Pulmonary Disease — Payments: $10,967
Rick Balestra, M.d, M.D
Pulmonary Disease — Payments: $9,856
Vikram Sahni, M.d, M.D
Pulmonary Disease — Payments: $4,784